Back
AUTHORIZATION 100% confidence via regex

GAZETTE NOTICE NO. 1879

GAZETTE NOTICE NO. 1879

THE PHARMACY AND POISONS ACT

(Cap. 244)

AUTHORIZATION


IT IS notified that Form 1: Application for Registration of a dietary supplement or borderline substance has been revised in accordance with the provisions of the Pharmacy and Poisons Act (Cap 244), The Pharmacy and Poisons (Registration of Drugs) Rules, Legal Notice Number 192 of 2010. The template application form below prescribes the minimum information required for submission of dossiers for registration of a dietary supplement or borderline substance seeking marketing authorization in Kenya. The dossiers should be submitted to the following address: The Registrar, Pharmacy and Poisons Board Lenana Road, P. O. Box 27663-00506, NAIROBI, KENYA For purposes of submission to PPB, an application for registration of herbal and complementary product shall include: (a) One duly filled application submitted as an electronic copy including their supporting documents - see Annex I: Application Form For Registration of Dietary Supplement or Borderline Substance below (b) Three (3) samples of the commercial pack(s). (c) Payment of requisite application fees described in the guideline document for dietary supplement or borderline substance issued by the Pharmacy and Poisons Board. (d) Any other information required and described in the guideline document for dietary supplement or borderline substance issued by the Pharmacy and Poisons Board. ANNEX I: APPLICATION FORM FOR REGISTRATION OF DIETARY SUPPLEMENT OR BORDELINE SUBSTANCE (to be submitted as an electronic copy) SECTION 1: PARTICULARS OF THE APPLICANT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time) SECTION 2: PARTICULARS OF THE DIETARY SUPPLEMENT OR BORDELINE SUBSTANCE (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board) SECTION 3: PARTICULARS OF THE MANUFACTURER(S) AND ACTIVITY DONE AT THE MANUFACTURING SITE(S) (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board) SECTION 4: COMPOSITION OF THE FINISHED PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board) SECTION 5: QUALITY SPECIFICATIONS AND ANALYTICAL PROCEDURES FOR ALL RAW MATERIALS USED IN THE PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time) SECTION 6: QUALITY SPECIFICATIONS AND ANALYTICAL PROCEDURES OF THE FINISHED PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time) SECTION 7: QUALITY SPECIFICATION AND ANALYTICAL PROCEDURES FOR THE PACKAGING MATERIAL USED IN THE FINISHED PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time) THE KENYA GAZETTE 21st March, 2014 740 740 SECTION 8: DETAILS OF THE MANUFACTURE AND PACKAGING OF THE FINISHED PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time) SECTION 9: STABILITY STUDIES OF THE FINISHED PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time) SECTION 10: SAFETY AND POST MARKET SURVEILLANCE PLAN OF THE FINISHED PRODUCT (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time) SECTION 11: ANY OTHER REFERENCE TO SUPPORT THE APPLICATION (as described in the guideline document for registration of a dietary supplement or borderline substance issued by the Pharmacy and Poisons Board from time to time) SECTION 12: DECLARATION BY AN APPLICANT which must be signed, dated and authenticated by an Official stamp. No received without properly authenticated declaration. • I, the undersigned certify that all the information in this form and accompanying documentation is correct, complete and true to the best of my knowledge. • I further confirm that the information referred to in my application file is available for verification during GMP inspection. • I also agree that I am obliged to follow the requirements of the Pharmacy and Poisons Board which are related to dietary supplement or borderline substance. • I also agree that the undersigned has not marketed or advertised this product in Kenya and will follow the PPB requirements for advertisements of medicines • I also agree that the undersigned will implement a Post-Market Surveillance plans for this product in accordance with PPB requirements • I also consent to the evaluation of information provided to the Pharmacy and Poisons Board. Name: ………… ……………………………………………..............… Position in the company: ………… …....…………………............…… Signature and Date: ………………………………………………… Official stamp: ………… ………………………………...........……… Dated the 8th January, 2014. K. C. KOSKEI, MR/4648206 Registrar.

Dated the 8th January, 2014.

K. C. KOSKEI,

Registrar.

Extracted Entities (1)

previous_gazette_ref

1879

Details

Act / Legislation
THE PHARMACY AND POISONS ACT
Reference
Cap. 244
Section
section 1
Signed By
K. C. KOSKEI
Title
Registrar
Date Signed
8th January 2014
Page
35
Extraction Method
regex